Bottom line
Ro (formerly Roman/Rory) is one of the largest direct-to-consumer telehealth platforms in the U.S. Their weight loss program — Ro Body — offers GLP-1 prescribing through an asynchronous intake, with medication delivered to your door. The experience is polished, the app is well-designed, and the speed from signup to first shipment is competitive.
Price: Varies by medication and plan. Compounded semaglutide programs have run $149-399/month; brand-name options are higher and depend on insurance.
Best for: patients who want a frictionless, app-first experience and are comfortable with asynchronous (text-based) provider interactions.
Not ideal for: patients who want face-to-face video visits, deep clinical supervision, or robust insurance navigation.
What the program includes
Ro Body's GLP-1 program typically includes:
- Asynchronous provider intake (text-based questionnaire reviewed
by a licensed prescriber, often within 24 hours)
- Medication prescribed and shipped via Ro's pharmacy partner
(cold-chain delivery)
- Ongoing provider messaging through the Ro app
- Automatic refill and titration scheduling
- Basic metabolic health content in the app
Ro has historically leaned heavily on compounded semaglutide as its primary GLP-1 offering, pricing it well below brand-name alternatives. With the FDA declaring the semaglutide shortage resolved in early 2025, Ro has been transitioning its offerings — but the specific medication options and pricing structure evolve frequently. Check their current offerings at signup.
Our intake experience
Day 1: Online questionnaire — health history, current medications, height, weight, goals. Took about 10 minutes. Upload a photo ID. No video visit required.
Day 1-2: Asynchronous provider review. A licensed prescriber reviewed our intake and sent a few follow-up questions via the app's messaging system. Prescription approved within 36 hours.
Day 4-5: Medication shipped and delivered via overnight cold-chain courier.
Total time from signup to first dose: 4-5 days. Among the fastest we've tested. The lack of a required video visit is the speed advantage — and also the clinical trade-off.
The asynchronous model: convenience vs depth
Ro's biggest differentiator is also its most debatable feature: the intake is entirely text-based. You never see or speak to your prescriber face-to-face.
Advantages:
- Faster: no scheduling, no video call, no waiting room
- Available outside business hours
- Lower friction for patients uncomfortable with video visits
- Works well for straightforward cases (young, healthy,
BMI ≥30, no complex medical history)
Limitations:
- The prescriber cannot observe you, ask real-time follow-up
questions, or pick up on non-verbal cues
- Complex medical histories (cardiac conditions, multiple
medications, eating disorder history, psychiatric medications) get less thorough evaluation in a text exchange
- Patients with questions often find asynchronous messaging
slow — you send a question, wait hours for a reply
- The relationship with your provider is transactional
rather than relational
For patients who are healthy, have a straightforward obesity profile, and mainly need the prescription and the medication — the asynchronous model works fine. For patients with medical complexity, we'd prefer a program with real-time video visits and deeper clinical engagement.
Pricing and medication
Ro's pricing has shifted as the compounded GLP-1 landscape has changed. Historically:
- Compounded semaglutide: $149-299/month (during the shortage
era)
- Brand-name options: higher, typically involving insurance or
manufacturer savings cards
In 2026, with the semaglutide shortage resolved and FDA enforcement increasing, Ro's medication offerings are in transition. The specific drugs available and their pricing may differ from what was advertised even months ago. We recommend checking current pricing at intake and specifically asking:
- "Is this compounded or brand-name?"
- "Is this legally available under current FDA rules?"
- "What happens to my prescription if this medication becomes
unavailable?"
Ro's pricing generally undercuts brand-name-only programs but is higher than the manufacturer direct channels (LillyDirect, NovoCare) when comparing brand-name products.
Clinical support
Ro Body's clinical model is lean:
- Provider access: asynchronous messaging. Response times
vary from hours to a day.
- Titration management: automated scheduling with provider
review. You'll be prompted to check in at dose-change intervals.
- Side effect support: handled via messaging. For acute
issues, you're directed to your PCP or urgent care.
- Nutrition guidance: basic content in the app, not
personalized dietitian access.
- Behavioral support: none included.
- Lab work: may be ordered but not always required at
intake depending on your profile. Labs are your responsibility to schedule and pay for.
This is the minimum viable clinical model for GLP-1 prescribing. It works for uncomplicated patients. It's less than what a patient with multiple medications, cardiac history, or a history of disordered eating should accept.
Who should choose Ro Body
Strong fit:
- Patients who want the fastest possible path to a GLP-1
with minimal friction
- Healthy patients with straightforward obesity (no complex
comorbidities)
- Patients comfortable managing their own nutrition, exercise,
and behavioral work
- Patients who prefer texting over video calls
Less ideal:
- Patients with cardiac history, complex medication lists, or
psychiatric comorbidities — the asynchronous model doesn't support the depth of evaluation these patients need
- Patients who want insurance to cover the medication —
Ro's insurance navigation is less developed than PlushCare's or Mochi's
- Patients who want a relationship with their prescriber,
not just a prescription
- Patients seeking the lowest possible cash price on
brand-name drugs — manufacturer direct programs (LillyDirect, NovoCare) are typically cheaper
What this means for you
Ro Body is a well-executed consumer product. The app is clean, the delivery is fast, and the experience is frictionless. If your needs are simple — you want a GLP-1, you're otherwise healthy, and you don't need a lot of clinical hand-holding — Ro delivers.
If your needs are more complex, Ro's model may be too thin. A program with video visits, integrated nutrition, and deeper provider relationships (Form Health, Mochi) is worth the extra cost and friction for patients who need it.